← Open Payments lookup

LATCHMIE RAMSAYWACK: Open Payments

NPI 1952983090 · JERSEY CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,024 in 64 payments from 12 companies in 2025. Trend: 2023 $663 · 2024 $1,546 · 2025 $2,024

Food & beverage: $2,024
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP22$1,062
GlaxoSmithKline, LLC.20$541
Viatris Specialty LLC5$147
Verona Pharma, Inc.3$51
ANI Pharmaceuticals, Inc.2$34
Regeneron Healthcare Solutions, Inc.2$34
Electromed, Inc.3$34
Amgen Inc.2$33
United Therapeutics Corporation2$32
CVRx, Inc.1$21

Products named: FASENRA, NUCALA, BREZTRI, YUPELRI, TEZSPIRE, TRELEGY ELLIPTA, Ohtuvayre, AIRSUPRA.

Industry payments across NJ — which companies pay providers there.